Markus Kammann Selected Research

Cimicifuga extract BNO 1055

7/2012	Osteoprotective effects of Cimicifuga racemosa and its triterpene-saponins are responsible for reduction of bone marrow fat.
6/2012	Cimicifuga racemosa and its triterpene-saponins prevent the Metabolic Syndrome and deterioration of cartilage in the knee joint of ovariectomized rats by similar mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Kammann Research Topics

Disease

1	Obesity 07/2012
1	Osteoporosis 07/2012
1	Arteriosclerosis 07/2012
1	Type 2 Diabetes Mellitus (MODY) 07/2012
1	Body Weight (Weight, Body) 06/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012
1	Osteoarthritis 06/2012

Drug/Important Bio-Agent (IBA)

2	TriterpenesIBA 07/2012 - 06/2012
2	Cimicifuga extract BNO 1055IBA 07/2012 - 06/2012
2	SaponinsIBA 07/2012 - 06/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 07/2012
1	AdipokinesIBA 07/2012
1	CytokinesIBA 07/2012